Healthcare provider profile · identity verified

Michael L Zaruba, MD

Family Practice · AUBURN, NE · NPI 1386749547

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	314	73
Levothyroxine Sodium	Levothyroxine Sodium	231	51
Pantoprazole Sodium	Pantoprazole Sodium	219	43
Omeprazole	Omeprazole	209	42
Amlodipine Besylate	Amlodipine Besylate	207	47
Lisinopril	Lisinopril	170	42
Simvastatin	Simvastatin	151	33
Losartan Potassium	Losartan Potassium	148	40
Tamsulosin Hcl	Tamsulosin Hcl	144	35
Metformin Hcl	Metformin Hcl	140	31
Metoprolol Succinate	Metoprolol Succinate	127	31
Gabapentin	Gabapentin	124	30
Arexvy	Rsvpref3 Antigen/As01e/Pf	115	115
Jardiance	Empagliflozin	114	19
Xarelto	Rivaroxaban	110	11
Eliquis	Apixaban	103	13
Hydrochlorothiazide	Hydrochlorothiazide	103	17
Furosemide	Furosemide	99	24
Clopidogrel	Clopidogrel Bisulfate	97	23
Metoprolol Tartrate	Metoprolol Tartrate	96	23
Meloxicam	Meloxicam	91	24
Duloxetine Hcl	Duloxetine Hcl	85	20
Potassium Chloride	Potassium Chloride	83	17
Prednisone	Prednisone	78	41
Carvedilol	Carvedilol	75	25
Alprazolam	Alprazolam	71	26
Warfarin Sodium	Warfarin Sodium	68	13
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	64	34
Shingrix	Varicella-Zoster Ge/As01b/Pf	64	47
Allopurinol	Allopurinol	63	20
Montelukast Sodium	Montelukast Sodium	61	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	57	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	56	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	55	suppressed
Lorazepam	Lorazepam	54	15
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	51	13
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	50	50
Mirtazapine	Mirtazapine	46	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	44	12
Methylprednisolone	Methylprednisolone	42	34
Rosuvastatin Calcium	Rosuvastatin Calcium	41	13
Trazodone Hcl	Trazodone Hcl	41	suppressed
Celecoxib	Celecoxib	40	11
Finasteride	Finasteride	40	suppressed
Ropinirole Hcl	Ropinirole Hcl	39	suppressed
Solifenacin Succinate	Solifenacin Succinate	38	suppressed
Synthroid	Levothyroxine Sodium	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	37	suppressed
Clonazepam	Clonazepam	36	14
Venlafaxine Hcl Er	Venlafaxine Hcl	36	suppressed
Donepezil Hcl	Donepezil Hcl	34	suppressed
Metformin Hcl Er	Metformin Hcl	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	suppressed
Cefuroxime	Cefuroxime Axetil	33	31
Ezetimibe	Ezetimibe	32	suppressed
Pregabalin	Pregabalin	32	11
Benazepril Hcl	Benazepril Hcl	31	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Atenolol	Atenolol	30	suppressed
Ozempic	Semaglutide	29	suppressed
Fenofibrate	Fenofibrate	28	suppressed
Oxycodone Hcl	Oxycodone Hcl	28	13
Topiramate	Topiramate	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Glimepiride	Glimepiride	27	suppressed
Bupropion Xl	Bupropion Hcl	26	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	26	suppressed
Ventolin Hfa	Albuterol Sulfate	26	suppressed
Glipizide Er	Glipizide	25	suppressed
Paroxetine Hcl	Paroxetine Hcl	25	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Alendronate Sodium	Alendronate Sodium	22	suppressed
Citalopram Hbr	Citalopram Hydrobromide	22	suppressed
Estradiol	Estradiol	21	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	21	suppressed
Glipizide	Glipizide	21	suppressed
Buspirone Hcl	Buspirone Hcl	20	suppressed
Tramadol Hcl	Tramadol Hcl	20	12
Albuterol Sulfate Hfa	Albuterol Sulfate	19	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	18	suppressed
Fluticasone Propionate	Fluticasone Propionate	18	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	17	suppressed
Ibuprofen	Ibuprofen	16	suppressed
Levofloxacin	Levofloxacin	16	11
Methocarbamol	Methocarbamol	16	suppressed
Baclofen	Baclofen	15	suppressed
Diazepam	Diazepam	15	suppressed
Famotidine	Famotidine	15	suppressed
Fentanyl	Fentanyl	15	suppressed
Ipratropium Bromide	Ipratropium Bromide	15	suppressed
Ketoconazole	Ketoconazole	15	suppressed
Divalproex Sodium	Divalproex Sodium	14	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	14	13
Verapamil Er	Verapamil Hcl	14	suppressed
Colchicine	Colchicine	13	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Mounjaro	Tirzepatide	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	13	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Vilazodone Hcl	Vilazodone Hcl	13	suppressed
Albuterol Sulfate	Albuterol Sulfate	12	suppressed
Azithromycin	Azithromycin	12	11
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Diclofenac Sodium	Diclofenac Sodium	12	suppressed
Famciclovir	Famciclovir	12	suppressed
Humalog Kwikpen U-100	Insulin Lispro	12	suppressed
Methotrexate	Methotrexate Sodium	12	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	12	suppressed
Symbicort	Budesonide/Formoterol Fumarate	12	suppressed
Valacyclovir	Valacyclovir Hcl	12	suppressed
Febuxostat	Febuxostat	11	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	11	suppressed
Incruse Ellipta	Umeclidinium Bromide	11	suppressed
Latanoprost	Latanoprost	11	suppressed
Levetiracetam	Levetiracetam	11	suppressed
Linzess	Linaclotide	11	suppressed
Omeprazole-Sodium Bicarbonate	Omeprazole/Sodium Bicarbonate	11	suppressed
Propafenone Hcl Er	Propafenone Hcl	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Risperidone	Risperidone	11	suppressed
Spironolactone	Spironolactone	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error